Trial: 202001099

A Phase II Randomized Trial of Olaparib Versus Olaparib Plus Tremelimumab in Platinum-Sensitive Recurrent Ovarian Cancer

Phase

II

Principal Investigator

Mutch, David

Disease Site

Other Female Genital; Ovary

Learn more about this study at: clinicaltrials.gov